Allogene Therapeutics, Inc.
INDUCIBLE CHIMERIC CYTOKINE RECEPTORS
Last updated:
Abstract:
The present invention provides inducible chimeric cytokine receptors responsive to a ligand, e.g., a small molecule or protein, uses of such receptors for improving the functional activities of genetically modified immune cells, such as T cells, comprising the inducible chimeric cytokine receptors, and compositions comprising such cells.
Status:
Application
Type:
Utility
Filling date:
1 Mar 2019
Issue date:
26 Sep 2019